Endothelin-1 exacerbates development of hypertension and atherosclerosis in modest insulin resistant syndrome
Authors:
- 1 May 2015
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 460 (3) , 497-503
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology (NSC 91-2314-B-075-101)
- Veterans General Hospitals University System of Taiwan (VGHUST 96-G1-2)
- Taipei Veterans General Hospital (VGH-TPE V98C1-006)
This publication has 30 references indexed in Scilit:
- Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1This article is one of a selection of papers published in the special issue (part 1 of 2) on Forefronts in Endothelin.Canadian Journal of Physiology and Pharmacology, 2008
- Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertensionNutrition, Metabolism and Cardiovascular Diseases, 2006
- Selective Insulin Resistance Affecting Nitric Oxide Release But Not Plasminogen Activator Inhibitor-1 Synthesis in Fibroblasts From Insulin-Resistant IndividualsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Insulin infusion induces endothelin-1-dependent hypertension in ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Insulin Receptor Substrate-1/SHP-2 Interaction, a Phenotype-dependent Switching Machinery of Insulin-like Growth Factor-I Signaling in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2004
- Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signallingBiochemical Journal, 2003
- Insulin Induces Heterologous Desensitization of G Protein-Coupled Receptor and Insulin-Like Growth Factor I Signaling by Downregulating β-Arrestin-1Molecular and Cellular Biology, 2002
- Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance.Journal of Clinical Investigation, 1998
- Endothelin-1 and Endothelin Receptor mRNA Expression in Normal and Atherosclerotic Human ArteriesBiochemical and Biophysical Research Communications, 1993
- Binding and receptor down‐regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cellsFEBS Letters, 1988